The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.

Saved in:

Bibliographic Details
Title:	The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.
Authors:	Tunitsky-Lifshitz, Yulia^1,2, Maoz-Segal, Ramit¹, Niznik, Stanley¹, Shavit, Ronen¹, Yahia, Soad Haj^1,2, Langevitz, Pnina^2,3, Agmon-Levin, Nancy^1,2 nancy.agmonlevin@sheba.health.gov.il
Source:	Lupus. Apr2023, Vol. 32 Issue 5, p675-679. 5p.
Database:	Academic Search Ultimate

Description
ISSN:	09612033
DOI:	10.1177/09612033231164262